Paul F. Truex, President and CEO at Anthera Pharmaceuticals Inc (ANTH), sold 15,000 shares at $6.34 ($95K) on 2011-12-15, disclosed to the SEC on 2011-12-16.
Scheduled sale ($95k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANTH | BUY | 2012-07-02 | $15K | — | Filing → |
| ANTH | SELL | 2012-02-17 | $118K | — | Filing → |
| ANTH | SELL | 2012-01-19 | $101K | — | Filing → |